POLATUZUMAB
UNII ME5E8BU5ST

Substance Identification & Data

This profile provides standardized clinical and technical data for Polatuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ME5E8BU5ST.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ME5E8BU5ST
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
POLATUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
Polatuzumab
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Polatuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

Immunoglobulin G1, anti-(human gene B29 protein) (human-Mus musculus monoclonal MCDS4409A heavy chain), disulfide with human-Mus musculus monoclonal MCDS4409A κ-chain, dimer
Polatuzumab

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record